Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mesoblast

11.69
-0.0800-0.68%
Post-market: 11.27-0.4182-3.58%19:09 EDT
Volume:98.47K
Turnover:1.15M
Market Cap:1.49B
PE:-12.67
High:11.85
Open:11.71
Low:11.61
Close:11.77
Loading ...

Mesoblast Seeks FDA Meeting for Accelerated Approval of Revascor

TIPRANKS
·
03 Apr

Mesoblast Files Request for Type B Meeting with FDA to Discuss Accelerated Approval Pathway for Revascor® in Ischemic Heart Failure

GlobeNewswire
·
03 Apr

Mesoblast (ASX:MSB) Announces Ryoncil Availability But Sees 15% Price Drop Over Past Week

Simply Wall St.
·
03 Apr

Mesoblast's Ryoncil to be Reimbursed by Medicaid

MT Newswires Live
·
31 Mar

Mesoblast Secures Medicaid Coverage for Ryoncil, Expanding Access for Pediatric Patients

TIPRANKS
·
31 Mar

BRIEF-Mesoblast Says Co Entered Medicaid National Drug Rebate Agreement With US CMS For Ryoncil

Reuters
·
31 Mar

Mesoblast Enters Agreement for Ryoncil Treatment Access in US

MT Newswires Live
·
31 Mar

Mesoblast announces it entered into NDRA with CMS DHHS for Ryoncil

TIPRANKS
·
31 Mar

First Three Children to Commence Treatment With Ryoncil®

GlobeNewswire
·
31 Mar

Mesoblast Ltd - Entered Into Medicaid National Drug Rebate Agreement With U.S. CMS for Ryoncil

THOMSON REUTERS
·
31 Mar

Mesoblast Says Mesenchymal Stromal Cell Therapy Commercially Available in US

MT Newswires Live
·
27 Mar

Thursday’s HotCopper Trends: Mesoblast bags FDA tick, Hot Chili extends mine life | March 27, 2025

The Market Herald
·
27 Mar

Why Domain, Mesoblast, Pro Medicus, and Tuas shares are tumbling today

MotleyFool
·
27 Mar

Ryoncil® is Now Available for Purchase in the United States

GlobeNewswire
·
27 Mar

Mesoblast's Ryoncil Becomes Available for Purchase in US

MT Newswires Live
·
27 Mar

Mesoblast’s Ryoncil Gains Comprehensive U.S. Drug Pricing Compendia Inclusion

TIPRANKS
·
14 Mar

Mesoblast Lists Pricing for FDA-Approved Inflammatory Disease Treatment

MT Newswires Live
·
14 Mar

Ryoncil® Product Information Now Available in All Four Major Drug Pricing Compendia in United States

GlobeNewswire
·
14 Mar

Mesoblast CEO to Present at ISCT Virtual Town Hall on Groundbreaking Cell Therapy

TIPRANKS
·
12 Mar

Investors push Mesoblast (ASX:MSB) 18% lower this week, company's increasing losses might be to blame

Simply Wall St.
·
11 Mar